[Basic principles of thrombolytic therapy].
D001565:Benzoates / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology; D001826:Body Fluids / Q000201:enzymology; D002395:Catecholamines / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004792:Enzyme Precursors / Q000378:metabolism; D004967:Estrogens / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D005341:Fibrinolysin; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000494:pharmacology; D006496:Heparinoids / Q000494:pharmacology; D006801:Humans; D009539:Nicotinic Acids / Q000494:pharmacology; D010958:Plasminogen / Q000378:metabolism; D011749:Pyrogens / Q000494:pharmacology; D013923:Thromboembolism / Q000188:drug therapy; D014044:Tolbutamide / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D001565:Benzoates; D002395:Catecholamines; D004792:Enzyme Precursors; D004967:Estrogens; D005227:Fatty Acids; D005343:Fibrinolytic Agents; D006496:Heparinoids; D009539:Nicotinic Acids; D011749:Pyrogens; D014667:Vasopressins; D010958:Plasminogen; D006493:Heparin; D014044:Tolbutamide; D005341:Fibrinolysin
Grundlagen der thrombolytischen Behandlung.